Table 1 Clinical characteristics of NPC patients according to the high and low expression levels of C2orf40
Characteristics | No. of patients | Expression of C2orf40 | P value | |
|---|---|---|---|---|
Low, n (%) | High, n (%) | |||
Age | ||||
 ≤ 45 | 34 | 15 (44.1) | 19 (55.9) | 0.37 |
 > 45 | 62 | 32 (51.6) | 30 (48.4) | |
Sex | ||||
 Male | 72 | 37 (51.4) | 35 (48.6) | 0.409 |
 Female | 24 | 10 (41.7) | 14 (58.3) | |
T stage | ||||
 T1–T2 | 47 | 19 (40.4) | 28 (59.6) | 0.101 |
 T3–T4 | 49 | 28 (57.1) | 21 (42.9) | |
N stage | ||||
 N0–N1 | 27 | 7 (25.9) | 20 (74.1) |  < 0.01 |
 N2–N3 | 69 | 40 (58.0) | 29 (42.0) | |
TNM stage | ||||
 I–II | 13 | 0 (0) | 13 (100.0) |  < 0.01 |
 III–V | 83 | 47 (56.6) | 36 (43.4) | |
Distant metastasis | ||||
 No | 90 | 42 (46.7) | 48 (53.3) | 0.082 |
 Yes | 6 | 5 (83.3) | 1 (16.7) | |
Death | ||||
 Yes | 67 | 22 (32.8) | 45 (67.2) |  < 0.01 |
 No | 29 | 25 (86.2) | 4 (13.8) | |